News
-
-
-
PRESS RELEASE
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Abivax strengthens commercial capabilities with strategic leadership appointments, preparing for potential U.S. commercialization of obefazimod. Abivax expands Commercial Leadership Team with industry leaders -
-
-
-
-
-
-
REGULATED PRESS RELEASE
LNA SANTE : Turnover H1 2026
LNA Santé reports strong performance in turnover and operations for the 1st half of 2026, exceeding guidance with operating revenue of €465.1m. Key growth areas include French Healthcare and Medical-Social sectors, Real Estate turnover, and international operations